EP3134386
ÍSÓINDÓLÍN-1-ON AFLEIÐUR SEM KÓLÍNVIRK M1-VIÐTAKAJÁKVÆÐ STÝRINÆM MÓTARAVIRKNI TIL MEÐFERÐAR VIÐ ALZHEIMER-SJÚKDÓMI
:
EP einkaleyfi í gildi á Íslandi:
22.4.2015:
20.5.2020:
15726362.5
:
10.8.2020:
15.9.2020
:
21.4.2035:
21.4.2026:
30.4.2026
:
ISOINDOLINE-1-ONE DERIVATIVES AS CHOLINERGIC MUSCARINIC M1 RECEPTOR POSITIVE ALLOESTERIC MODULATOR ACTIVITY FOR THE TREATMENT OF ALZHEIMERS DISEASE
22.4.2015
20.5.2020
10.8.2020
15.9.2020
21.4.2026
:
Takeda Pharmaceutical Company Limited:
1-1, Doshomachi 4-chome Chuo-ku, Osaka- shi, Osaka 541-0045, JP
:
YAMADA, Masami:
Fujisawa-shi Kanagawa 251-0012, JP
:
SUZUKI, Shinkichi:
Fujisawa-shi Kanagawa 251-0012, JP
:
SUGIMOTO, Takahiro:
Fujisawa-shi Kanagawa 251-0012, JP
:
NAKAMURA, Minoru:
Fujisawa-shi Kanagawa 251-0012, JP
:
SAKAMOTO, Hiroki:
Fujisawa-shi Kanagawa 251-0012, JP
:
KAMATA, Makoto:
Fujisawa-shi Kanagawa 251-0012, JP
:
Budde Schou A/S:
Dronningens Tværgade 30, DK
:
2014089585:
23.4.2014:
JP
:
JP2015062912:
22.4.2015
:
C07D 209/46, A61K 31/435, A61P 29/00
: 7
: 10.3.2021
: 21.4.2022
: Árnason Faktor ehf.
: 8
: 22.3.2022
: 21.4.2023
: Patice ehf.
: 9
: 25.3.2023
: 21.4.2024
: Árnason Faktor ehf.
: 10
: 20.3.2024
: 21.4.2025
: Árnason Faktor ehf.
: 11
: 8.4.2025
: 21.4.2026
: Árnason Faktor ehf.